Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119752894 | 11975289 | 4 | F | 2011 | 20160909 | 20160128 | 20160916 | EXP | US-DSJP-DSU-2015-120140 | DAIICHI | 0.00 | Y | 0.00000 | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119752894 | 11975289 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | U | 21286 | 20 | MG | TABLET | QD | |||||
| 119752894 | 11975289 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40MG/25 MG, QD | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 119752894 | 11975289 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, UNK | Y | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 119752894 | 11975289 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 112 ?G, UNK | 0 | 112 | UG | |||||||||
| 119752894 | 11975289 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | 100 IU, UNK | 0 | 100 | IU | |||||||||
| 119752894 | 11975289 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, UNK | 0 | 1000 | MG | BID | |||||||
| 119752894 | 11975289 | 7 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG, UNK | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119752894 | 11975289 | 1 | Product used for unknown indication |
| 119752894 | 11975289 | 2 | Hypertension |
| 119752894 | 11975289 | 4 | Product used for unknown indication |
| 119752894 | 11975289 | 5 | Product used for unknown indication |
| 119752894 | 11975289 | 6 | Product used for unknown indication |
| 119752894 | 11975289 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119752894 | 11975289 | HO |
| 119752894 | 11975289 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119752894 | 11975289 | Anaemia | |
| 119752894 | 11975289 | Colon adenoma | |
| 119752894 | 11975289 | Gastrointestinal haemorrhage | |
| 119752894 | 11975289 | Haemorrhoids | |
| 119752894 | 11975289 | Hiatus hernia | |
| 119752894 | 11975289 | Impaired gastric emptying | |
| 119752894 | 11975289 | Irritable bowel syndrome | |
| 119752894 | 11975289 | Malabsorption | |
| 119752894 | 11975289 | Renal failure | |
| 119752894 | 11975289 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119752894 | 11975289 | 2 | 2011 | 2013 | 0 |